Abstract

BackgroundRecent GWAS studies have identified more than 300 SNPs associated with variation in blood pressure. We investigated whether a genetic risk score constructed from these variants is associated with burden of coronary heart disease.MethodsFrom 2010–2014, 4,809 individuals admitted to coronary angiography in Capital Region of Copenhagen were genotyped. We calculated hypertension GRS comprised of GWAS identified SNPs associated with blood pressure. We performed logistic regression analyses to estimate the risk of hypertension and prevalent CHD. We also assessed the severity of CHD associated with the GRS. The analyses were performed using GRS quartiles. We used the Inter99 cohort to validate our results and to investigate for possible pleiotropy for the GRS with other CHD risk factors.ResultsIn COGEN, adjusted odds ratios comparing the 2nd, 3rd and 4th cumulative GRS quartiles with the reference were 1.12(95% CI 0.95–1.33), 1.35(95% CI 1.14–1.59) and 1.29(95% CI 1.09–1.53) respectively, for prevalent CHD. The adjusted multinomial logistic regression showed that 3rd and 4th GRS quartiles were associated with increased odds of developing two(OR 1.33, 95% CI 1.04–1.71 and OR 1.36, 95% CI 1.06–1.75, respectively) and three coronary vessel disease(OR 1.77, 95% CI 1.36–2.30 and OR 1.65, 95% CI 1.26–2.15, respectively). Similar results for incident CHD were observed in the Inter99 cohort. The hypertension GRS did not associate with type 2 diabetes, smoking, BMI or hyperlipidemia.ConclusionHypertension GRS quartiles were associated with an increased risk of hypertension, prevalent CHD, and burden of coronary vessel disease in a dose-response pattern. We showed no evidence for pleiotropy with other risk factors for CHD.

Highlights

  • Hypertension has been estimated to account for >45% of all coronary heart disease (CHD) events worldwide [1]

  • Hypertension GRS quartiles were associated with an increased risk of hypertension, prevalent CHD, and burden of coronary vessel disease in a dose-response pattern

  • We showed no evidence for pleiotropy with other risk factors for CHD

Read more

Summary

Introduction

Hypertension has been estimated to account for >45% of all coronary heart disease (CHD) events worldwide [1]. The relation between genetic determinants of hypertension and the development of CHD can be important for understanding disease mechanisms. More than 300 single nucleotide polymorphisms (SNPs) with relation to hypertension have been identified in genome-wide association studies (GWAS) [2], [3]. The relation between these many hypertension associated SNPs and occurrence of CHD has received limited attention. A single study has indicated a dose-response relationship of increased risk of CHD associated with the number of hypertension associated SNPs [4]. We investigated whether a genetic risk score constructed from these variants is associated with burden of coronary heart disease

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call